awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30315301-63FAC8AB-9E8C-46B0-9D0E-98B2308BEBE1
Q30315301-63FAC8AB-9E8C-46B0-9D0E-98B2308BEBE1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30315301-63FAC8AB-9E8C-46B0-9D0E-98B2308BEBE1
ABC3 Consensus: Assessment by a German Group of Experts
P2860
Q30315301-63FAC8AB-9E8C-46B0-9D0E-98B2308BEBE1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30315301-63FAC8AB-9E8C-46B0-9D0E-98B2308BEBE1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eb7ce20897e693a0f5e8ad4f1dd3bb161f15eca5
P2860
Overall survival benefit with lapatinib in combination with trastuzumab for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: final results from the EGF104900 Study.